A carregar...
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]
Na minha lista:
| Publicado no: | Clinicoecon Outcomes Res |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5261548/ https://ncbi.nlm.nih.gov/pubmed/28174493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S118835 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|